Mostrando entradas con la etiqueta diabetes. Mostrar todas las entradas
Mostrando entradas con la etiqueta diabetes. Mostrar todas las entradas

martes, 2 de enero de 2024

Efecto de los corticosteroides preoperatorios sobre el control de glucosa posoperatorio en artroplastia articular total

 https://www.traumaysiniestros.com.mx/academia/efecto-de-los-corticosteroides-preoperatorios-sobre-el-control-de-glucosa-posoperatorio-en-artroplastia-articular-total/


Efecto de los corticosteroides preoperatorios sobre el control de glucosa posoperatorio en artroplastia articular total

Sus pacientes reciben dexametasona antes de la TJA? Este estudio de @LoyolaOrthoRes, @LoyolaHealth
investigó sus efectos sobre el control de la glucosa en pacientes diabéticos y no diabéticos. #ortotwitter @bellkneesurgeon
@AlexisGaskin32, @_AndyHarrisMD, @jsanzreig

Effect of Preoperative Corticosteroids on Postoperative Glucose Control in Total Joint Arthroplasty – Arthroplasty Today

Effect of Preoperative Corticosteroids on Postoperative Glucose Control in Total Joint Arthroplasty – PubMed (nih.gov)

Effect of Preoperative Corticosteroids on Postoperative Glucose Control in Total Joint Arthroplasty – PMC (nih.gov)

Effect of Preoperative Corticosteroids on Postoperative Glucose Control in Total Joint Arthroplasty – Arthroplasty Today

Denyer S, Ramini A, Eikani C, Murphy MP, Brown N. Effect of Preoperative Corticosteroids on Postoperative Glucose Control in Total Joint Arthroplasty. Arthroplast Today. 2023 Nov 21;24:101238. doi: 10.1016/j.artd.2023.101238. PMID: 38077928; PMCID: PMC10700152.

This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

lunes, 28 de enero de 2019

Diabetes

Enero 28,  2020 No. 3322


 




2. Clasificación y diagnóstico de la diabetes 2019
2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2019.
Diabetes Care. 2019 Jan;42(Suppl 1):S13-S28. doi: 10.2337/dc19-S002.
Abstract
The American Diabetes Association (ADA) "Standards of Medical Care in Diabetes" includes ADA's current clinical practice recommendations and is intended to provide the components of diabetes care, general treatment goals and guidelines, and tools to evaluate quality of care. Members of the ADA Professional Practice Committee, a multidisciplinary expert committee, are responsible for updating the Standards of Care annually, or more frequently as warranted. For a detailed description of ADA standards, statements, and reports, as well as the evidence-grading system for ADA's clinical practice recommendations, please refer to the Standards of Care Introduction Readers who wish to comment on the Standards of Care are invited to do so at professional.diabetes.org/SOC.
Diabetes. Daños y Tratamiento
Diabetes. Damages and Treatments
São Paulo State University
Intech
 
Over the last few decades the prevalence of diabetes has dramatically grown in most regions of the world. In 2010, 285 million people were diagnosed with diabetes and it is estimated that the number will increase to 438 million in 2030. Hypoglycemia is a disorder where the glucose serum concentration is usually low. The organism usually keeps the serum glucose concentration in a range of 70 to 110 mL/dL of blood. In hypoglycemia the glucose concentration normally remains lower than 50 mL/dL of blood. Hopefully, this book will be of help to many scientists, doctors, pharmacists, chemicals, and other experts in a variety of disciplines, both academic and industrial. In addition to supporting researcher and development, this book should be suitable for teaching.
Convocatoria para Capítulos sobre Anestésicos Locales
Call for Book Chapters on Local Anesthetics
Congresos Médicos por Especialidades en todo Mundo
Medical Congresses by Specialties around the World
Safe Anaesthesia Worldwide
Delivering safe anaesthesia to the world's poorest people
Like us on Facebook   Follow us on Twitter   Find us on Google+   View our videos on YouTube 
Anestesiología y Medicina del Dolor

52 664 6848905

lunes, 8 de enero de 2018

Diabetes y embarazo / Diabetes and pregnancy

Enero 8, 2018. No. 2957
Manejo de la diabetes en el embarazo: Estándares del cuidado médico en diabetes : 2018
Management of Diabetes in Pregnancy: Standards of Medical Care in Diabetes: 2018
Diabetes Care 2018;41(Suppl. 1):S137-S143 | https://doi.org/10.2337/dc18-S013
The American Diabetes Association (ADA) "Standards of Medical Care in Diabetes" includes ADA's current clinical practice recommendations and is intended to provide the components of diabetes care, general treatment goals and guidelines, and tools to evaluate quality of care. Members of the ADA Professional Practice Committee, a multidisciplinary expert committee, are responsible for updating the Standards of Care annually, or more frequently as warranted. For a detailed description of ADA standards, statements, and reports, as well as the evidence-grading system for ADA's clinical practice recommendations, please refer to the Standards of Care Introduction. Readers who wish to comment on the Standards of Care are invited to do so at professional.diabetes.org/SOC.
Diabetes y embarazo: Manejo de la diabetes y sus complicaciones desde la preconcepción al periodo postnatal
Diabetes in Pregnancy: Management of Diabetes and Its Complications from Preconception to the Postnatal Period.
Editors
National Collaborating Centre for Women's and Children's Health (UK).
Source
London: National Institute for Health and Care Excellence (UK); 2015 Feb.
National Institute for Health and Care Excellence: Clinical Guidelines .
Excerpt
Clinical guidelines have been defined as 'systematically developed statements which assist clinicians and patients in making decisions about appropriate treatment for specific conditions'. This clinical guideline concerns the management of diabetes and its complications from preconception to the postnatal period. It has been developed with the aim of providing guidance on: preconception information; diagnosis and management of gestational diabetes; glycaemic control in the preconception, antenatal and intrapartum periods; changes to medications for diabetes and its complications before or during pregnancy; management of diabetic emergencies (for example, hypoglycaemia and ketoacidosis) and diabetic complications (such as retinopathy) during pregnancy; the timetable of antenatal appointments to be offered to women with diabetes; timing and mode of birth (including induction of labour, caesarean section, analgesia and anaesthesia, and the use of steroids for fetal lung maturation); initial care of the newborn baby; management of diabetes and its complications during the postnatal period.
Diabetes mellitus y el anestesiólogo, cuidados perioperatorios
Elsa Elisa Jiménez Morales, Rogelio Sánchez García
Revista de Investigación Médica Sur, México Vol. 15, núm. 1, Enero-Marzo 2008
Resumen
La diabetes mellitus es uno de los padecimientos con mayor prevalencia, por lo que los médicos involucrados en su manejo antes, durante y después de un acto quirúrgico, deben conocer su terapéutica. Los criterios actuales de diagnóstico para diabetes son: síntomas de diabetes (poliuria, polidipsia, y pérdida de peso inexplicable) más el resultado de una muestra aleatoria mayor o igual a 200 mg/dL de glucosa, glucosa en ayuno (> 8 horas) de 126 mg/dL o mayor. Glucosa mayor o igual a 200 mg/dL 2 horas después de la administración oral de 75 g de glucosa. Los protocolos de manejo perioperatorio de pacientes diabéticos aceptados actualmente son tres y se conocen como; régimen clásico amplio, régimen estricto tipo I y escala móvil. Palabras clave: alabras clave: Diabetes mellitus, cuidados perioperatorios, anestesiología.

Safe Anaesthesia Worldwide
Delivering safe anaesthesia to the world's poorest people
World Congress on Regional Anesthesia & Pain Medicine
April 19-21, 2018, New York City, USA
Like us on Facebook   Follow us on Twitter   Find us on Google+   View our videos on YouTube 
Anestesiología y Medicina del Dolor

52 664 6848905

martes, 18 de julio de 2017

Enfermedades cardiovasculares y diabetes / Cardiovascular disease and diabetes

Julio 15, 2017. No. 2750






Enfermedades cardiovasculares y diabetes. ¡Dos caras de la misma moneda!
Cardiovascular Disease and Diabetes: Two Sides of the Same Coin!
Sayeeda Rahman, Md. Anwarul Azim Majumder, Russell Kabir, Mainul Haque, Subir Gupta, Sana Mohammad Yasir Arafat, Nkemcho Ojeh and Prasad Dalvi
Recent Trends in Cardiovascular Risks
Abstract
Cardiovascular disease (CVD) and type 2 diabetes (T2DM) are rapidly rising around the globe. Empirical researches demonstrated rapid increase in mortality and morbidity related to CVD and T2DM. Much of the diabetes-associated morbidity and mortality predominantly reflects its deleterious effect on macrovascular and microvascular diseases. The microvascular complications of T2DM include retinopathy, neuropathy and nephropathy and the macrovascular complications include ischemic heart disease, cerebrovascular disease and peripheral vascular diseases. Research indicates that coronary heart disease (CHD) is the major cause of mortality in people with T2DM. Herein, this chapter reviews relationship between CVD and T2DM, associated complications and effectiveness of relevant treatment modalities to treat/prevent diabetic macrovasculopthy. Macrovascular disease occur due to underlying obstructive atherosclerotic changes of major arteries which cause functional and structural abnormalities of blood vessels. The long-term complications can be controlled and prevented by controlling glycemia, maintaining normal lipid profiles, adopting a healthy lifestyle and using pharmacological interventions. Clinical trials have shown that lifestyle interventions help in prevention and reduction of CVD risk, but evidence for long-term CVD outcomes is lacking. A multidisciplinary approach involving patients, health professionals and researchers and governments should be undertaken to reduce the incidence and prevalence of diabetesrelated cardiovascular complications. Keywords: cardiovascular diseases, type 2 diabetes, vasculopathy, macrovascular diseases, atherosclerosis, pathophysiology, pathogenesis

Refinación de la predicción a largo plazo del riesgo cardiovascular en la diabetes - La puntuación de VILDIA.
Refining Long-Term Prediction of Cardiovascular Risk in Diabetes - The VILDIA Score.
Sci Rep. 2017 Jul 5;7(1):4700. doi: 10.1038/s41598-017-04935-8.
Abstract
Cardiovascular risk assessment in patients with diabetes relies on traditional risk factors. However, numerous novel biomarkers have been found to be independent predictors of cardiovascular disease, which might significantly improve risk prediction in diabetic patients. .... The VILDIA score based on traditional cardiovascular risk factors and reinforced with novel biomarkers outperforms previous risk algorithms.

XIV Congreso Virtual Mexicano de Anestesiología 2017
Octubre 1-Diciembre 31, 2017
Información / Information
Like us on Facebook   Follow us on Twitter   Find us on Google+   View our videos on YouTube 
Anestesiología y Medicina del Dolor

52 664 6848905